HFB200603
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HFB200603, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors [Phase 1]